JNJ Stock Recent News

This is a tricky time for investors. Most people agree that valuations have reached alarmingly high levels.

The U.S. drug regulator said on Friday Ethicon Endo-Surgery, a unit of Johnson & Johnson , issued a correction for certain lots of a part related to its surgical stapler and classified the action as "most serious".

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3rd, 2025. Management will participate in a Fireside Chat at 11:50 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast replay will be available ap.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

JNJ's Innovative Medicine unit posts solid Q2 growth despite Stelara's LOE, powered by Darzalex, Tremfya, Erleada and new drugs.

The Dividend Income Accelerator Portfolio delivers a 3.98% yield and 7.11% five-year dividend growth, balancing income and growth for strong risk-adjusted returns. Our portfolio is globally diversified, with reduced company and sector concentration risk, enhancing stability and lowering overall risk. Large-cap, value-focused holdings dominate, further reducing risk and supporting consistent dividend growth over time.

Key Points ETFs have generated higher returns than mutual funds. GLD, VYM, and QQQ have the potential to outpace S&P 500. Are you ahead, or behind on retirement? SmartAsset’s free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don’t waste another minute; get started by clicking here.(Sponsor) 2025 hasn’t been a smooth ride. The economy has seen volatility, the market has seen several ups and downs, and investors are scrambling to look for low-risk options to invest their money. There are concerns about the impact of tariffs, and consumer spending is low. Amidst the uncertainty, the only way to invest is to look for low-volatility investment options that can generate steady income. Exchange-traded funds have emerged as one of the top investment options this year. They allow investors to own a collection of stocks with just one investment and at a low cost. I was

Key Points The RSPA ETF will immediately turn the bulk of your $25,000 account into a diversified income machine. Smaller allocations into SCHD, JEPQ, and FDVV will help you build a low-fee passive income foundation. Are you ahead, or behind on retirement? SmartAsset’s free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don’t waste another minute; get started by clicking here.(Sponsor) How far can $25,000 get you? If you have a well-considered plan in place, you can actually turn your small account into a passive income factory. This can be done with a carefully selected group of high-yield, low-fee exchange traded funds (ETFs). With just $25,000, you can build a super-low-cost portfolio that consistently pays you cash dividends/distributions. Plus, you can de-risk your portfolio through multi-sector diversification and investment in famous large-cap companies. So, le

A wave of upgraded guidance from major U.S. companies is reshaping the outlook for the rest of 2025, and analysts are responding in kind. Strong Q2 earnings results have prompted several high-profile firms to lift their full-year forecasts, triggering a flurry of price target hikes across Wall Street.

What makes a good dividend stock? The answer depends a bit on who's looking, of course.